Rates and determinants of oral human papillomavirus infection in young men

Sexually Transmitted Diseases

Volumn 39, Issue 11, 2012, Pages 860-867

  Edelstein, Zoe R ^a   Schwartz, Stephen M ^b,c   Hawes, Stephen ^c   Hughes, James P ^c   Feng, Qinghua ^c   Stern, Michael E ^c   O'Reilly, Sandra ^c   Lee, Shu Kuang ^c   Fu Xi, Long ^c   Koutsky, Laura A ^c  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANNABIS SMOKING; CLINICAL EXAMINATION; ETHNICITY; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT INFECTION; MALE HOMOSEXUAL; MOUTH CAVITY; MOUTH INFECTION; ORAL SEXUAL CONTACT; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; QUESTIONNAIRE; SEXUALITY; SMOKING; THROAT CULTURE; VIRUS TRANSMISSION;

ADOLESCENT; DISTRICT OF COLUMBIA; DNA, VIRAL; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; MOUTH; MOUTH DISEASES; ODDS RATIO; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SEXUAL BEHAVIOR; SEXUAL PARTNERS; SMOKING; YOUNG ADULT;

EID: 84867745940     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e318269d098     Document Type: Article

References (31)

1. IARC WorkingGroupontheEvaluationofCarcinogenic RiskstoHumans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 2007; 90:1-636.
2. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal associ-ationbetween human papillomavirusandasubsetofheadandneckcancers. J Natl Cancer Inst 2000; 92:709-720. (Pubitemid 30365531)
3. Chaturvedi AK, Engels EA, Anderson WF, et al. Incidence trends for human papillomavirus-related and-unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008; 26:612-619. (Pubitemid 351264356)
4. Fast Stats. An interactive tool for access to SEER cancer statistics [online database]. Bethesda, MD. Surveillance Research Program, National Cancer Institute. Available at: http://seer.cancer.gov/faststats/. Accessed on December 10, 2011.
5. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011; 29:4294-4301.
6. Eike A, Buchwald C, Rolighed J, et al. Human papillomavirus (HPV) is rarely present in normal oral and nasal mucosa. Clin Otolaryngol Allied Sci 1995; 20:171-173.
7. Terai M, Hashimoto K, Yoda K, et al. High prevalence of human papil-lomaviruses in the normal oral cavity of adults. Oral Microbiol Immunol 1999; 14:201-205. (Pubitemid 29351034)
8. Gillison ML, Broutian T, Pickard RK, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012; 307:693-703.
9. D'Souza G, Fakhry C, Sugar EA, et al. Six-month natural history of oral versus cervical human papillomavirus infection. Int J Cancer 2007; 121:143-150. (Pubitemid 46753862)
10. Smith E, Swarnavel S, Ritchie J, et al. Prevalence of human papilloma-virus in the oral cavity/oropharynx in a large population of children and adolescents. Pediatr Infect Dis J 2007; 26:836-840. (Pubitemid 47329857)
11. D'Souza G, Agrawal Y, Halpern J, et al. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009; 199:1263-1269.
12. Kreimer AR, Villa A, Nyitray AG, et al. The epidemiology of oral HPV infection among a multinational sample of healthy men. Cancer Epidemiol Biomarkers Prev 2011; 20:172-182.
13. Rintala M, Grénman S, Puranen M, et al. Natural history of oral papillo-mavirus infections in spouses: A prospective Finnish HPV Family Study. J Clin Virol 2006; 35:89-94. (Pubitemid 43020959)
14. Kreimer A, Alberg A, Daniel R, et al. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis 2004; 189:686-698. (Pubitemid 38270923)
15. Fakhry C, D'souza G, Sugar E, et al. Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and-negative women. J Clin Microbiol 2006; 44:4479-4485. (Pubitemid 44937082)
16. Partridge JM, Hughes JP, Feng Q, et al. Genital human papillomavirus infection in men: Incidence and risk factors in a cohort of university students. J Infect Dis 2007; 196:1128-1136. (Pubitemid 47580267)
17. Feng Q, Cherne S, Winer R, et al. Development and evaluation of aliquid bead microarray assay for genotyping genital human papillomaviruses. J Clin Microbiol 2009; 47:547-553.
18. Wei L, Lin D, Weissfeld L. Regression analysis of multivariate incomplete failure time databymodeling marginal distributions. J Am Stat Assoc 1989; 84:1065-1073.
19. Lin D. Cox regression analysis of multivariate failure time data: The marginal approach. Stat Med 1994; 13:2233-2247. (Pubitemid 24343234)
20. Lawton G, Thomas S, Schonrock J, et al. Human papillomaviruses in normal oral mucosa: A comparison of methods for sample collection 1. J Oral Pathol Med 1992; 21:265-269.
21. Giuliano AR, Lee JH, Fulp W, et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): A cohort study. Lancet 2011; 377:932-940.
22. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006; 24(suppl 1):S1YS15.
23. Coutlée F, Trottier AM, Ghattas G, et al. Risk factors for oral human papillomavirus in adults infected and not infected with human immunodeficiency virus. Sex Transm Dis 1997; 24:23-31. (Pubitemid 27030474)
24. Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers 1. J Natl Cancer Inst 2008; 100:407-420. (Pubitemid 351480511)
25. Braakhuis B, Brakenhoff R, Meijer C, et al. Human papilloma virus in head and neck cancer: The need for a standardised assay to assess the full clinical importance. Eur J Cancer 2009; 45:2935-2939.
26. Eklund C, Forslund O, Wallin KL, et al. The 2010 global proficiency study of human papillomavirus genotyping in vaccinology. J Clin Microbiol 2012; 50:2289-2298.
27. Miller C, White D. Human papillomavirus expression in oral mucosa, premalignant conditions, and squamous cell carcinoma: A retrospective review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 82:57-68. (Pubitemid 126813002)
28. Varnai A, Bollmann M, Bankfalvi A, et al. The prevalence and distribution of human papillomavirus genotypes in oral epithelial hyperplasia: Proposal of a concept. J Oral Pathol Med 2009; 38:181-187.
29. Giuliano AR, Palefsky JM, Goldstone S, et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med 2011; 364:401-411.
30. The FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007; 356:1915-1927.
31. Palefsky JM, Giuliano AR, Goldstone S, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011; 365:1576-1585.